This variability in the ability to invade and migrate tumor cells across different CRC cell lines suggests that PRDX1 might predict prognosis and serve as a potential therapeutic target, regulating tumor metastasis and angiogenesis in colorectal cancer. This evidence concerns the gene PRDX1 and colorectal cancer.